Skip to content
Subscriber Only

Mylan Investigations Mount as West Virginia Opens Fraud Probe

  • West Virginia AG seeks court order on rebate documents
  • Morrisey calls EpiPen’s 500 percent price hike ‘outrageous’
Video player cover image

Mylan Plans Half-Priced Generic Version of EpiPen

Updated on

Mylan NV, already under fire from patients over the rising price of its EpiPen allergy shots, is facing a growing number of questions from lawmakers and law enforcement after the state of West Virginia launched a Medicaid fraud investigation into the drugmaker’s pricing Tuesday.

The inquiry, led by State Attorney General Patrick Morrisey, seeks to force Mylan to turn over company documents related to EpiPen. Similar requests have been made in the last month by lawmakers in Washington, and on Wednesday Mylan Chief Executive Officer Heather Bresch is to testify at a congressional hearing about the product’s price. The state attorneys general in Minnesota and New York also have inquiries, as do several congressional committees.